Pentacenequinones

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 50 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used for biochemical and pharmacological research. It demonstrates nanomolar inhibition of CK1δ and sub-micromolar inhibition of CK1ε, with reported Ki values and documented activity in both cell-based assays and in vivo xenograft models.

• Potent ATP-competitive inhibition of CK1δ and CK1ε.
• Nanomolar activity suitable for biochemical assays.
• Reported Ki of 97 nM for target binding.
• Validated in cell-based and in vivo xenograft studies.
• High purity to support reliable experimental results.
• Supplied as a stable solid for laboratory use.

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻1 | C23H19F3N8O | 2 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used in biochemical and cellular research. It exhibits nanomolar inhibition of CK1δ and CK1ε and is supplied as a high-purity research compound suitable for in vitro and cell-based assays.

• Potent ATP-competitive inhibition of CK1δ (IC50 44 nM) and CK1ε (IC50 260 nM).
• Ki approximately 97 nM for both kinases.
• High reported purity (99.73%), appropriate for biochemical assays.
• Available as a solid or as a 10 mM solution in DMSO for convenient handling.
• Molecular weight 480.45 g·mol⁻1; formula C23H19F3N8O.
• Suitable for kinase profiling and cell-based studies.

Medchemexpress LLC N-[(6,7-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g/mol | C23H19F3N8O | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

SR-3029 is a potent, ATP-competitive small-molecule inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) used as a research reagent in biochemical and cell-based studies. It shows low-nanomolar activity against CK1δ and selective activity against CK1ε, with additional reported activity across certain CDKs and FLT3 in kinase profiling.

• Potent ATP-competitive inhibition of CK1δ and CK1ε (IC50 44 nM and 260 nM).
• Ki of 97 nM for both CK1δ and CK1ε.
• High purity suitable for biochemical and cell-based assays.
• Available in multiple solid sizes and as DMSO solution for assay preparation.
• Supplied as a white to pink solid for ease of handling and storage.
• Molecular weight 480.45 g/mol, facilitating dose calculation.
• For research use only; not for human or clinical use.

Medchemexpress LLC N-[(6,7-difluoro-1h-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9h-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻¹ | C23H19F3N8O | 25 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) with characterized biochemical, cellular, and in vivo activity. It is used in kinase signaling and oncology research to probe CK1-dependent pathways and evaluate antiproliferative effects in cell and animal models.

• Potent ATP-competitive inhibitor of CK1δ and CK1ε (IC50s 44 nM and 260 nM).
• Ki of 97 nM against CK1 isoforms.
• Cellular antiproliferative activity with EC50s in the low nanomolar range.
• Demonstrated antitumor activity in multiple xenograft models.
• High reported purity (99.73%).
• Available as solid and solution formats for biochemical and cell-based assays.

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 100 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

SR-3029 is a small-molecule, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and casein kinase 1 epsilon (CK1ε), intended for research use in biochemical and cell-based studies. It exhibits potent enzyme inhibition and is provided in formats suitable for assay and formulation work.

• Potent ATP-competitive inhibition of CK1δ and CK1ε.
• Low-nanomolar activity against CK1δ (IC50 44 nM).
• Sub-micromolar activity against CK1ε (IC50 260 nM).
• Ki of 97 nM for both CK1δ and CK1ε.
• Chemical formula C23H19F3N8O and molecular weight 480.45.
• High purity (99.7%) suitable for research applications.
• Available as solid and as DMSO solution for experimental flexibility.